Logo
x

Search

Subscribe Now

elanco

Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

  • March 19, 2025
Elanco Launches Pet Protect Supplement Line for Dogs and Cats

Elanco Launches Pet Protect Supplement Line for Dogs and Cats

  • February 21, 2025
Elanco Reports the First Shipment of Varenzin-CA1 for Anemia associated with CKD in Felines within the US

Elanco Reports the First Shipment of Varenzin-CA1 for Anemia associated with CKD in Felines within the US

  • September 8, 2023
Top 20 Animal Health Companies Based on 2019 Revenue

Top 20 Animal Health Companies Based on 2019 Revenue

  • November 12, 2020
Elanco Receives the US FTC's Approval for Acquisition of Bayer Animal Health

Elanco Receives the US FTC's Approval for Acquisition of Bayer Animal Health

  • July 15, 2020
Elanco Receives EC's Approval for its Pending Acquisition of Bayer Animal Health

Elanco Receives EC's Approval for its Pending Acquisition of Bayer Animal Health

  • June 8, 2020
Elanco Animal Health Reports the US FDA’s Approval of Zenrelia (Ilunocitinib) to Treat Canine Dermatological Disorders

    Elanco Animal Health Reports the US FDA’s Approval of Zenrelia (Ilunocitinib) to Treat Canine Dermatological Disorders

    • September 20, 2024
    PharmaShots Weekly Snapshots (May 27 – May 31, 2024)

      PharmaShots Weekly Snapshots (May 27 – May 31, 2024)

      • May 31, 2024
      Elanco Reports the US FDA’s Review Completion of Bovaer to be Used Across the US Dairy Industry

        Elanco Reports the US FDA’s Review Completion of Bovaer to be Used Across the US Dairy Industry

        • May 29, 2024
        PharmaShots

          PharmaShots' Key Highlights of First Quarter 2024

          • April 1, 2024
          PharmaShots Weekly Snapshots (February 05 – February 09, 2024)

            PharmaShots Weekly Snapshots (February 05 – February 09, 2024)

            • February 9, 2024
            Merck Animal Health Reports Acquisition of Elanco Animal Health’s Aqua Business for ~$1.3B

              Merck Animal Health Reports Acquisition of Elanco Animal Health’s Aqua Business for ~$1.3B

              • February 6, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.